After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
CorMedix Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of CorMedix Inc is $581.07M. A total of 0.64 million shares were traded on the day, compared to an average of 827.52K shares.
In the most recent transaction, Todisco Joseph bought 13,561 shares of CRMD for 3.74 per share on Mar 13 ’24. After the transaction, the Chief Executive Officer now owns 352,839 company shares. In a previous transaction on Dec 14 ’23, DUNTON ALAN W bought 3,000 shares at 3.45 per share. CRMD shares that Director owns now total 12,250.
Among the insiders who bought shares, DUNTON ALAN W acquired of 3,000 shares on Dec 15 ’23 at a per-share price of $3.30. This resulted in the Director holding 15,250 shares of CRMD after the transaction. In another insider transaction, Mistry Erin bought 1,000 shares at $4.00 per share on Nov 17 ’23. Company shares held by the Chief Commercial Officer now total 4,900.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CRMD has a high of $10.17 and a low of $2.57.
As of this writing, CRMD has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.13. The company reported an EPS of -$0.17 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRMD’s latest balance sheet shows that the firm has $65.47M in Cash & Short Term Investments as of fiscal 2021. There were $923.80k in debt and $5.35M in liabilities at the time. Its Book Value Per Share was $0.84, while its Total Shareholder’s Equity was $62.80M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRMD is Buy with a score of 4.60.
